Neko Health has raised $700m, setting the company up with proceeds to scale its full-body scanning service ahead of the planned launch of its first US clinics this year.
Putting its funds raised to date at over $1bn, Neko’s Series C financing round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. New backers include Liberty City Ventures and Positive Sum, while individual investors, such as Meta CEO Mark Zuckerberg and former footballer Thierry Henry, also participated.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek – who is also the former CEO of music app Spotify – the health tech startup’s non-invasive Neko Health Scan diagnostic uses 70 scanners and a combination of technologies, including thermal imaging and 2D/3D photography, to map approximately 50 million health data points in a user’s body.
Neko has attracted considerable interest among Europe’s health tech scene since launching its first clinic in Stockholm, Sweden, in 2023. From there, the company launched its first UK site in Marylebone, London, in September 2024, and has since expanded its UK operations with three additional sites in London and one in Birmingham and Manchester.
Users attend one of Neko’s clinics and enter a chamber-like room. What follows is a 60-minute health assessment, priced at £299 in the UK and 2,750 SEK in Sweden. Throughout the session, vectors including skin health and metabolic composition are assessed, with biomarkers used to identify pre-diabetes risk, potential blood abnormalities, and risk factors linked to pathologies including metabolic syndrome, stroke, and heart attack. Patient’s recieve most results from the scan during a consultation immediately afterwards.
Neko has also recently added what it calls its “most significant” scan advancement to date. Now available at all existing clinics, the addition of body composition measures and clinician review of wearable data is designed to “give members an even more detailed picture of their health” in the moment and between visits, the company stated.
Concluding a $260m Series B fundraise in January 2025, Neko’s latest and largest fundraise to date, serves as ample testament to the ongoing demand for its services. According to Neko, over 350,000 people have joined the waitlist or registered for a Neko Health Scan, while more than 100,000 in the UK and Sweden have already experienced one.
Hiring Dr Sunita Mishra as chief medical officer (CMO) in March 2026, who previously served as CMO at Amazon Health, Neko is now eyeing expansion into the US, with its first site due to launch in New York this year.
Neko’s co-founder and CEO, Hjalmar Nilsonne, said: “This funding is a strong vote of confidence in what we set out to do when we opened our first clinic three years ago: a completely new healthcare experience designed to keep people healthy, catch problems early and help prevent disease before it even starts.
“With this round, we’re taking that mission to the US for the first time, while continuing to invest in the research and technology that make prevention possible at scale.”
